Industry
ADHD Market Going Out Of Control
December 2007 | Industry NewsA recent study published in the Journal of Child and Adolescent Psychiatry and Mental Health claims that the cost of drugs to treat Attention Deficit Hyperactivity Disorder (ADHD) could increase by as much as 10 fold in Europe for the decade to 2012. Although placing an additional burden on health services,
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
